Karimi M - Search Results

1

Frequency of cholelithiasis in patients with Beta-thalassemia intermedia with and without hydroxyurea.

Khavari M, Hamidi A, Haghpanah S, Bagheri MH, Bardestani M, Hantooshzadeh R, Karimi M. Khavari M, et al. Among authors: karimi m. Iran Red Crescent Med J. 2014 Jul;16(7):e18712. doi: 10.5812/ircmj.18712. Epub 2014 Jul 5. Iran Red Crescent Med J. 2014. PMID: 25237586 Free PMC article.

2

Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran.

Karimi M, Darzi H, Yavarian M. Karimi M, et al. J Pediatr Hematol Oncol. 2005 Jul;27(7):380-5. doi: 10.1097/01.mph.0000174386.13109.28. J Pediatr Hematol Oncol. 2005. PMID: 16012328

3

Prevalence of hepatosplenomegaly in beta thalassemia minor subjects in Iran.

Karimi M, Bagheri MH, Tahmtan M, Shakibafard A, Rashid M. Karimi M, et al. Eur J Radiol. 2009 Jan;69(1):120-2. doi: 10.1016/j.ejrad.2007.09.027. Epub 2007 Oct 29. Eur J Radiol. 2009. PMID: 18029131

4

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.

Karimi M, Borzouee M, Mehrabani A, Cohan N. Karimi M, et al. Eur J Haematol. 2009 Mar;82(3):213-8. doi: 10.1111/j.1600-0609.2008.01192.x. Epub 2008 Dec 5. Eur J Haematol. 2009. PMID: 19077048

5

Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot study.

Rasekhi AR, Naderifar M, Bagheri MH, Shahriari M, Foroutan H, Karimi M, Nabavizadeh SA. Rasekhi AR, et al. Among authors: karimi m. AJR Am J Roentgenol. 2009 May;192(5):1425-9. doi: 10.2214/AJR.08.1382. AJR Am J Roentgenol. 2009. PMID: 19380572

6

Malignancies in patients with beta-thalassemia major and beta-thalassemia intermedia: a multicenter study in Iran.

Karimi M, Giti R, Haghpanah S, Azarkeivan A, Hoofar H, Eslami M. Karimi M, et al. Pediatr Blood Cancer. 2009 Dec;53(6):1064-7. doi: 10.1002/pbc.22144. Pediatr Blood Cancer. 2009. PMID: 19533641

7

Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran.

Lotfi M, Keramati P, Assdsangabi R, Nabavizadeh SA, Karimi M. Lotfi M, et al. Among authors: karimi m. Med Sci Monit. 2009 Aug;15(8):CR398-402. Med Sci Monit. 2009. PMID: 19644415

8

Spectrum of inherited bleeding disorders in southern Iran, before and after the establishment of comprehensive coagulation laboratory.

Karimi M, Haghpanah S, Amirhakimi A, Afrasiabi A, Dehbozorgian J, Nasirabady S. Karimi M, et al. Blood Coagul Fibrinolysis. 2009 Dec;20(8):642-5. doi: 10.1097/MBC.0b013e32832f4371. Blood Coagul Fibrinolysis. 2009. PMID: 19710607

9

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia.

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S. Karimi M, et al. Eur J Haematol. 2010 Jan 1;84(1):52-8. doi: 10.1111/j.1600-0609.2009.01356.x. Epub 2009 Oct 3. Eur J Haematol. 2010. PMID: 19799627 Clinical Trial.

10

Hydroxyurea in the management of thalassemia intermedia.

Karimi M. Karimi M. Hemoglobin. 2009;33 Suppl 1:S177-82. doi: 10.3109/03630260903351809. Hemoglobin. 2009. PMID: 20001623 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,874 results

Search Page

Filters